Table 3 Association between the risk stratification for mortality in PH patients and COVID-19 severity and outcome
From: Impact and predictors of outcome of COVID-19 in pulmonary hypertension patients
Risk assessment | Low risk | Intermediate risk | High risk | P value for chi square |
|---|---|---|---|---|
Severity: | ||||
 Mild | 2 (50.0%) | 4 (40.0%) | 2 (28.6%) | 0.408 |
 Moderate | 1 (25.0%) | 5 (50.0%) | 1 (14.3%) |  |
 Severe | 0 (0.0%) | 1 (10.0%) | 1 (14.3%) |  |
 Critical | 1 (25.0%) | 0 (0.0%) | 3 (42.8%) |  |
Outcome | ||||
 Cure | 3 (75.0%) | 10 (100.0%) | 5 (71.4%) | 0.259 |
 Death | 1 (25.0%) | 0 (0.0%) | 2 (28.6%) |  |